Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) EBT Margin (2016 - 2025)

Historic EBT Margin for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to 17.16%.

  • Bio-Techne's EBT Margin rose 27300.0% to 17.16% in Q4 2025 from the same period last year, while for Dec 2025 it was 9.39%, marking a year-over-year decrease of 61400.0%. This contributed to the annual value of 8.07% for FY2025, which is 79500.0% down from last year.
  • Per Bio-Techne's latest filing, its EBT Margin stood at 17.16% for Q4 2025, which was up 27300.0% from 16.75% recorded in Q3 2025.
  • Over the past 5 years, Bio-Techne's EBT Margin peaked at 5185.8% during Q3 2022, and registered a low of 7.21% during Q2 2025.
  • In the last 5 years, Bio-Techne's EBT Margin had a median value of 18.26% in 2021 and averaged 276.42%.
  • Per our database at Business Quant, Bio-Techne's EBT Margin surged by 51596500bps in 2022 and then plummeted by -51679000bps in 2023.
  • Bio-Techne's EBT Margin (Quarter) stood at 32.0% in 2021, then fell by -24bps to 24.46% in 2022, then crashed by -50bps to 12.25% in 2023, then grew by 18bps to 14.43% in 2024, then rose by 19bps to 17.16% in 2025.
  • Its EBT Margin stands at 17.16% for Q4 2025, versus 16.75% for Q3 2025 and 7.21% for Q2 2025.